| Literature DB >> 20671972 |
Agnieszka B Olejniczak1, Jan Milecki, Grzegorz Schroeder.
Abstract
CONJUGATES OF PURINE AND PYRIMIDINE NUCLEOSIDES: thymidine and 2'-deoxyguanosine with cobalt-metallacarborane were studied for their sodium ion complexing properties. Formation of stable complexes of 1 : 1 stoichiometry was proved by ESI MS spectroscopy and (23)Na NMR. Equilibrium constants and energies of complex formation were calculated. Complexation of alkali-metals by nucleoside-metallacarborane conjugates may affect the physicochemical and biological properties of the conjugates and should be taken into consideration during biological evaluation of these types of modifications.Entities:
Year: 2010 PMID: 20671972 PMCID: PMC2909723 DOI: 10.1155/2010/196064
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Schematic structures of the conjugates: ({5-[3-cobalt bis(1,2-dicarbollide)-8-yl]-3-oxa-pentoxy}-2′-O-deoxyguanosine)−, 1–3 and ({5-[3-cobalt bis(1,2-dicarbollide)-8-yl]-3-oxa-pentoxy}thymidine)−, 4–6.
Calculated enthalpy of formation (ΔH ) [kJ/mol] for complexing core of complexes of 1–6 with sodium cations (PM5 method), where X = 3-cobalt bis(1, 2-dicarbollide).
|
|
Figure 1Example ESI MS spectra for compounds 1–3 (cv = 30 V) and 4–6 (cv = 70 V), in methanol, negative regions.
The main peaks in the ESI mass spectra recorded for negative ions and relative intensity of signals for metallacarborane-2′-deoxyguanosine conjugates 1–3, and metallacarborane-thymidine conjugates 4–6, at various cone voltages.
|
| |||||
|---|---|---|---|---|---|
| No | Molecular formula | Cone voltage (cv) [V] | |||
| MW* | 30 | 50 | 70 | 90 | |
|
| C18H41N5O6B18Co | 486 (22%); (M-C)− 552 (100%); (M-A)− 678 (22%); M− | 552 (100%); (M-A)− 678 (18%); M− | 486 (20%); (M-C)− 552 (20%); (M-A)− 678 (100%); M− | 486 (100%); (M-C)− 552 (20%); (M-A)− 678 (22%); M− |
|
| |||||
|
| C18H41N5O6B18Co | 678; M− | 561 (20%); (M-B)− 678 (100%); M− | 561 (40%); (M-B)− 678 (100%); M− | 561 (80%); (M-B)− 678 (100%); M− |
|
| |||||
|
| C18H41N5O6B18Co | 561 (100%); (M-B)− 678 (trace); M− | 561; (M-B)− 677 (trace); M− | 561; (M-B)− 678 (trace); M− | 561; (M-B)− 678 (trace); M− |
|
| |||||
|
| C18H42N2O7B18Co, | 653; M− | 536 (100%); (M-E)− 653 (25%); M− | 410 (15%); (M-D)− 536 (80%); (M-E)− 653 (100%); M− | 410 (30%); (M-D)− 536 (100%); (M-E)− 653 (25%); M− |
|
| |||||
|
| C18H42N2O7B18Co | 653; M− | 536 (10%); (M-E)− 653 (100%); M− | 410 (10%), (M-D)− 536 (60%); (M-E)− 653 (100%); M− | 536 (90%); (M-E)− 653 (100%); M− |
|
| |||||
|
| C18H42N2O7B18Co | 653; M− | 410 (10%); (M-D)− 536 (100%); (M-E)− 653 (20%); M− | 410 (10%); (M-D)− 536 (20%); (M-E)− 653 (100%); M− | 410 (10%); (M-D)− 536 (100%); (M-E)− 653 (20%); M− |
*Calculation of the theoretical molecular mass for compounds 1–6 was performed using option “Analyze Structure” in ChemDraw Program. The calculated masses provided in the manuscript correspond to molecular weight (MW) based on the average mass of the elements consisting natural isotopes.
Where (for 1–3): M− m/z = 678 (B18C18CoH41N5O6), (M-A)− m/z = 552 (B17C13CoH33N5O3), (M-B)− m/z = 561 (B18C13CoH33N5O3), (M-C)− m/z = 486 (B9C16H30N5O6).
Where (for 4–6): M− m/z = 653 (B18C18CoH42N2O7), (M-D)− m/z = 410 (B18C8CoH29O2), (M-E)− m/z = 536 (B18C13CoH34N2O4).
Figure 2The theoretical and experimental m/z = 678 ESI MS signals (left) and m/z = 561 ESI MS signals (right) for compound 3, negative regions.
Figure 3ESI MS spectra for compound 3 m/z = 500–700 at various cone voltages cv = 30, 50, 70, 90, 110 V, negative regions.
Figure 4The experimental and theoretical m/z = 725 (B18C18CoH41N5O6Na2) ESI MS spectra of the complex of compound 3 (left), and m/z = 698 (B18C18CoH42N2O7Na2) ESI MS spectra of the complex of compound 4 (right), with NaClO4, positive regions.